NCT04937179

Brief Summary

Lower limb amputation is common in the United States, with approximately 150,000 amputations annually. Most individuals walking with a prosthesis demonstrate asymmetrical loading-i.e., they favor the amputated side by placing more weight and increased ground reaction forces through the intact limb-which likely contributes to increased metabolic cost of walking. Lack of adequate muscular strength in the lower limb to attenuate these forces places increased stress on the joints, which may be displaced proximally, and may play a role in reported knee and hip pain in the intact limb. Lower limb muscle weakness following amputation has been well documented. Increasing quadriceps strength is important after an amputation because it is positively correlated with gait speed. Gait speed may also be associated with successful community mobility, which leads to improved quality of life following amputation. Individuals with amputation who resume an active lifestyle are able to maintain strength. However, these individuals represent a minority of persons with lower limb amputation; most individuals report more barriers than motivators to adopt an active lifestyle. Ischemic conditioning (IC) may strengthen leg muscles and reduce the metabolic cost of activity after amputation. In IC, the limb is exposed to brief, repeated bouts of ischemia (reduced blood flow) immediately followed by reperfusion. IC has been shown to improve muscle performance in healthy and diseased populations. IC has also been used more recently in patients with peripheral artery disease (PAD) as an intervention to improve function, such as walking ability. Acute exposure to IC increases muscle strength and activation, both in healthy, active individuals and in those with severe neuromuscular dysfunction, such as stroke survivors. IC also attenuates muscular fatigue. Increased fatigue resistance at submaximal contraction levels following IC may be due to increased neural activation of skeletal muscle. Changes in neural activation of muscle may be particularly beneficial during cortical reorganization after amputation. Reduced quadriceps fatigue during submaximal activities may also drive changes in gait kinematics, such as increased knee flexion during loading and mid-stance. Exposure to IC may also increase the oxidative properties of skeletal muscle, offering a direct pathway to reduce metabolic cost. Therefore, IC may lead to cellular changes that lower the metabolic cost of activity. The primary aim of this study is to quantify the benefits of acute and chronic IC on quadriceps strength and walking economy in individuals with PAD and history of lower limb amputation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 23, 2021

Completed
1 year until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 27, 2025

Status Verified

February 1, 2025

Enrollment Period

2.5 years

First QC Date

May 27, 2021

Last Update Submit

February 25, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in quadriceps strength

    Quadriceps strength assessed by a Biodex dynamometer

    through study completion, an average of 6 weeks

  • Change in gait kinematics

    Gait mechanics assessed by joint angles using Vicon cameras and reflective markers

    through study completion, an average of 6 weeks

  • Change in gait kinetics

    Gait mechanics assessed by joint forces using a Bertec instrumented treadmill in combination with gait kinematics

    through study completion, an average of 6 weeks

  • Change in gait metabolics

    Assessment of oxygen consumption during walking using a metabolic cart

    through study completion, an average of 6 weeks

Secondary Outcomes (1)

  • Six-minute walk test

    through study completion, an average of 6 weeks

Study Arms (2)

Ischemic Conditioning Low

SHAM COMPARATOR

Blood flow restriction with low compression

Procedure: Ischemic Conditioning Low - Sham Comparator

Ischemic Conditioning High

ACTIVE COMPARATOR

Blood flow restriction with high compression

Procedure: Ischemic Conditioning High - Active Comparator

Interventions

The use of a Hokanson rapid inflator cuff to restrict blood flow at 25mmHg for 5 minutes followed by a 5 minute reperfusion period, repeated for 5 cycles.

Ischemic Conditioning Low

The use of a Hokanson rapid inflator cuff to restrict blood flow at 225mmHg for 5 minutes followed by a 5 minute reperfusion period, repeated for 5 cycles.

Ischemic Conditioning High

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Able to ambulate independently without the use of aids (i.e., walking cane)
  • Able to walk at least 10 minutes continuously without stopping
  • History of diagnosed peripheral artery disease.
  • For Amputees: History lower limb unilateral transtibial or transfemoral amputation.

You may not qualify if:

  • Inability to give informed consent
  • neurological disorder that affects gait
  • two or more falls within the previous 12 months
  • currently pregnant (or intend to become pregnant while participating in study)
  • history of any condition where fatiguing contractions or resisted leg contractions are contraindicated
  • blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg).
  • history of hypertension
  • history of heart failure
  • Head injury within the previous 6 months
  • Seizure disorder
  • Adverse reaction to ultrasound gel
  • History of thrombosis
  • History of sickle cell trait

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UIC Physical Therapy Faculty Practice

Chicago, Illinois, 60608, United States

Location

MeSH Terms

Conditions

Peripheral Arterial DiseasePeripheral Vascular DiseasesWounds and Injuries

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Lindsay Slater, PhD

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 23, 2021

Study Start

July 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 27, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations